Tag Archive for: Tryp
Tryp Therapeutics Has Completed Psychotherapist Training for a Planned Clinical Trial to Investigate Psilocybin Therapy for IBS
Business, ResearchTryp completes their Phase 2a psilocybin for IBS clinical trial training for psychotherapists at Massachusetts General Hospital.
Math Over Myth: These Psychedelic Stocks Made Confirmed Bottoms in Q3
Business, Stock ReportsMath over Myth is your weekly update on psychedelic stocks and ETFs, including ATAI, COMPASS, Cybin, GH Research, Mindset, Numinus, and more
Math Over Myth: Weekly Psychedelic Stocks News Roundup
Business, Stock ReportsGet the latest news on psychedelic stocks Cybin, Numinus, MindMed, ATAI, Mindset, Braxia, Tryp, Irwin Naturals, and Revive